Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Date
Availability
1-20 of 436
Title: obesity
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
American Diabetes Association Professional Practice Committee, Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, Kirthikaa Balapattabi, Elizabeth A. Beverly, Kathaleen Briggs Early, Dennis Bruemmer, Justin B. Echouffo-Tcheugui, Laya Ekhlaspour, Rajesh Garg, Kamlesh Khunti, Robert F. Kushner, Rayhan Lal, Ildiko Lingvay, Glenn Matfin, Naushira Pandya, Elizabeth J. Pekas, Scott J. Pilla, Sarit Polsky, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Raveendhara R. Bannuru
Journal:
Diabetes Care
Diabetes Care 2025;48(Supplement_1):S167–S180
Published: 09 December 2024
... information is available at https://www.diabetesjournals.org/journals/pages/license . Obesity is a chronic, often relapsing disease with numerous metabolic, physical, and psychosocial complications, including a substantially increased risk for the development and progression of type 2 diabetes ( 1...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):325–334
Published: 15 November 2024
...W. Timothy Garvey Semaglutide and tirzepatide have recently been approved for obesity and found to achieve ≥15% weight loss in clinical trials. These drugs have been referred to as second-generation medications because the unprecedented degree of weight loss they afford is sufficient to treat...
Journal Articles
Helena H. Laroche, Cristina Fernandez, Brooke R. Sweeney, Meredith L. Dreyer Gillette, Sarah E. Hampl
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):313–324
Published: 15 November 2024
...Helena H. Laroche; Cristina Fernandez; Brooke R. Sweeney; Meredith L. Dreyer Gillette; Sarah E. Hampl Prevalence rates of pediatric obesity and diabetes are rising, and pediatric health care professionals are ideally situated to address these chronic diseases using a patient- and family-centered...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):275–279
Published: 15 November 2024
... is available at https://www.diabetesjournals.org/journals/pages/license . UAB Diabetes Research Center P30 DK079626 P30 DK079626 National Institutes of Health 10.13039/100000002 The prevalence of obesity is rising worldwide ( 1 ), and obesity was found to affect 42% of U.S. adults...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):303–312
Published: 15 November 2024
...Sarah H. Schmitz; Louis J. Aronne Second-generation anti-obesity medications are more effective than their first-generation predecessors, resulting in an average weight loss of 15% when combined with lifestyle modifications. This article examines the efficacy and therapeutic implications...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):296–302
Published: 15 November 2024
...Sarah R. Barenbaum; Mohini Aras The development of second-generation anti-obesity medications (AOMs) has transformed the treatment of obesity. However, the first-generation AOMs are still essential tools in the treatment of obesity. The decision of which AOM to initiate must be individualized...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(4):281–295
Published: 15 November 2024
...Ariana M. Chao; Alexandra Paul; Josef V. Hodgkins; Thomas A. Wadden This article summarizes and compares 18 sets of guidelines for adult obesity treatment, highlighting key recommendations for patient evaluation, lifestyle intervention, anti-obesity medications (AOMs), and metabolic and bariatric...
Journal Articles
Journal:
Diabetes Care
Diabetes Care 2025;48(1):84–92
Published: 05 November 2024
...Bettina Mittendorfer; Bruce W. Patterson; Gordon I. Smith; Mihoko Yoshino; Samuel Klein OBJECTIVE To evaluate total, insulin-mediated, and non–insulin-mediated glucose disposal (TGD, IMGD, and NIMGD) after ingesting glucose in people with obesity and different glycemic status. RESEARCH DESIGN...
Journal Articles
Journal:
Diabetes Care
Diabetes Care 2024;47(12):2196–2204
Published: 07 October 2024
...Resthie R. Putri; Thomas Casswall; Pernilla Danielsson; Claude Marcus; Emilia Hagman OBJECTIVE To assess 1) the association between metabolic dysfunction–associated steatotic liver disease (MASLD) in pediatric obesity and youth-onset type 2 diabetes, 2) the joint effect of MASLD...
Journal Articles
Christopher L. Axelrod, Adithya Hari, Wagner S. Dantas, Sangeeta R. Kashyap, Philip R. Schauer, John P. Kirwan
Journal:
Diabetes Care
Diabetes Care 2024;47(11):2024–2032
Published: 23 September 2024
.../license . Graphical Abstract Cleveland Clinic 10.13039/100007311 LifeScan 10.13039/100004719 National Institute of Diabetes and Digestive and Kidney Diseases 10.13039/100000062 DK089547 Ethicon Endo-Surgery 10.13039/100005566 EES IIS 19900 Obesity...
Journal Articles
Steven E. Kahn, John E. Deanfield, Ole Kleist Jeppesen, Scott S. Emerson, Trine Welløv Boesgaard, Helen M. Colhoun, Robert F. Kushner, Ildiko Lingvay, Bartolome Burguera, Grzegorz Gajos, Deborah Bade Horn, Irene M. Hramiak, Ania M. Jastreboff, Alexander Kokkinos, Michael Maeng, Ana Laura S.A. Matos, Francisco J. Tinahones, A. Michael Lincoff, Donna H. Ryan, SELECT Trial Investigators
Journal:
Diabetes Care
Diabetes Care 2024;47(8):1350–1359
Published: 22 June 2024
...; Francisco J. Tinahones; A. Michael Lincoff; Donna H. Ryan; SELECT Trial Investigators OBJECTIVE To determine whether semaglutide slows progression of glycemia in people with cardiovascular disease and overweight or obesity but without diabetes. RESEARCH DESIGN AND METHODS In a multicenter, double-blind...
Journal Articles
Ildiko Lingvay, John Deanfield, Steven E. Kahn, Peter E. Weeke, Hermann Toplak, Benjamin M. Scirica, Lars Rydén, Naveen Rathor, Jorge Plutzky, Cristobal Morales, A. Michael Lincoff, Michael Lehrke, Ole Kleist Jeppesen, Grzegorz Gajos, Helen M. Colhoun, Bertrand Cariou, Donna Ryan, SELECT Trial Investigators
Journal:
Diabetes Care
Diabetes Care 2024;47(8):1360–1369
Published: 22 June 2024
... Investigators OBJECTIVE To evaluate the cardiovascular effects of semaglutide by baseline glycated hemoglobin (HbA1c) and change in HbA1c in a prespecified analysis of Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT). RESEARCH DESIGN...
Journal Articles
Journal:
Diabetes Care
Diabetes Care 2024;47(11):1873–1888
Published: 06 June 2024
...Daniel J. Drucker The development of glucagon-like peptide 1 receptor agonists (GLP-1RA) for type 2 diabetes and obesity was followed by data establishing the cardiorenal benefits of GLP-1RA in select patient populations. In ongoing trials investigators are interrogating the efficacy...
Journal Articles
Journal:
Clinical Diabetes
Clin Diabetes 2024;42(2):204–205
Published: 15 April 2024
... is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license . A holistic approach to obesity management is essential, encompassing nutrition counseling, regular exercise, behavioral strategies, and diabetes self...
Journal Articles
Angelo Sabag, Matthew N. Ahmadi, Monique E. Francois, Svetlana Postnova, Peter A. Cistulli, Luigi Fontana, Emmanuel Stamatakis
Journal:
Diabetes Care
Diabetes Care 2024;47(5):890–897
Published: 10 April 2024
... (MVD), and all-cause mortality in adults with obesity and a subset with obesity and type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS Participants included adults with obesity (BMI ≥30 kg/m2) and a subset of those with T2D from the UK Biobank accelerometry substudy. Aerobic MVPA...
Journal Articles
Journal:
Diabetes Care
Diabetes Care 2024;47(8):1246–1256
Published: 27 March 2024
... have been proposed or enacted to improve insulin affordability and foster greater equity in access. These policies have implications for other diabetes and obesity therapeutics. Recent legislation, at both the state and federal level, has capped insulin out-of-pocket payments for some patients. Other...
Journal Articles
Lise Folon, Morgane Baron, Victoria Scherrer, Bénédicte Toussaint, Emmanuel Vaillant, Hélène Loiselle, Aurélie Dechaume, Frédérique De Pooter, Raphaël Boutry, Mathilde Boissel, Aboubacar Diallo, Lijiao Ning, Beverley Balkau, Guillaume Charpentier, Sylvia Franc, Michel Marre, Mehdi Derhourhi, Philippe Froguel, Amélie Bonnefond
Journal:
Diabetes Care
Diabetes Care 2024;47(3):444–451
Published: 03 January 2024
...; Philippe Froguel; Amélie Bonnefond OBJECTIVE Rare variants in DYRK1B have been described in some patients with central obesity, type 2 diabetes, and early-onset coronary disease. Owing to the limited number of conducted studies, the broader impact of DYRK1B variants on a larger scale has...
Journal Articles
Cheng Zu, Mengyi Liu, Xinyue Su, Yuanxiu Wei, Qiguo Meng, Chengzhang Liu, Ziliang Ye, Xiaoqin Gan, Yuanyuan Zhang, Panpan He, Chun Zhou, Fan Fan Hou, Xianhui Qin
Journal:
Diabetes Care
Diabetes Care 2024;47(3):371–378
Published: 11 December 2023
.../obesity and type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS Included in this study were 3,601 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial. Body weight TTR was defined...
Journal Articles
American Diabetes Association Professional Practice Committee, Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Robert F. Kushner, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pilla, Sarit Polsky, Priya Prahalad, Richard E. Pratley, Alissa R. Segal, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal:
Diabetes Care
Diabetes Care 2024;47(Supplement_1):S145–S157
Published: 11 December 2023
...://www.diabetesjournals.org/journals/pages/license . Obesity is a chronic, often relapsing disease with numerous metabolic, physical, and psychosocial complications, including a substantially increased risk for type 2 diabetes ( 1 ). There is strong and consistent evidence that obesity management can delay...
Journal Articles
Journal:
Diabetes Spectrum
Diabetes Spectr 2024;37(1):65–85
Published: 16 October 2023
... health (mHealth) improve A1C, blood glucose, BMI, and/or weight among Hispanic/Latino adults with type 2 diabetes or overweight/obesity in the Americas. Design and methods Searches were conducted in June 2021 using the Scientific Electronic Library Online, Cumulative Index of Nursing and Allied...
1
